Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mylan
Pharma
Viatris settles opioid claims, agreeing to pay up to $335M
Viatris has agreed to a settlement in which it will pay up to $335 million to resolve opioid-related claims to state and local governments.
Kevin Dunleavy
Apr 7, 2025 10:48am
FDA warning letter reveals production errors at Viatris plant
Jan 6, 2025 4:20pm
Novo settles with Mylan over potential Ozempic generic
Oct 7, 2024 9:18am
Viatris, former president cleared in DOJ price-fixing probe
Jul 2, 2024 9:40am
Viatris official Rayapureddy cleared of insider trading charges
Jan 30, 2024 8:30am
Biogen notches another Tecfidera patent win in Europe
Dec 19, 2023 9:30am
